Day: May 22, 2020

MONTRÉAL, May 22, 2020 (GLOBE NEWSWIRE) — Le Château Inc. (the “Company”) (TSX VENTURE: CTU) today announced that due to logistics and delays caused by the COVID-19 virus, it is relying on the exemption provided by Decision No 2020-PDG-0023 of the Autorité des marchés financiers (the “Decision”) and equivalent exemptions provided by the Ontario Securities Commission, the Manitoba Securities Commission, the Saskatchewan Securities Commission, the Alberta Securities Commission and the British Columbia Securities Commission to postpone the filing of the following continuous disclosure documents (collectively, the “Annual Documents”):the Company’s annual audited consolidated financial statements for the year ended January 25, 2020 as required by section 4.2 of National Instrument 51-102 – Continuous...

MONTRÉAL, 22 mai 2020 (GLOBE NEWSWIRE) — Le Château Inc. (la « Société ») (TSX CROISSANCE : CTU) a annoncé aujourd’hui que pour des questions de logistique et en raison des retards entraînés par le virus COVID-19, elle se prévaut de la dispense accordée par la Décision n°2020-PDG-0023 de l’Autorité des marchés financiers (la « Décision ») ainsi que des dispenses équivalentes accordées par la Commission des valeurs mobilières de l’Ontario, la Commission des valeurs mobilières du Manitoba, la Saskatchewan Securities Commission, l’Alberta Securities Commission et la British Columbia Securities Commission pour reporter le dépôt des documents d’information continue suivants (collectivement, les « documents annuels ») :les états financiers consolidés annuels audités de la Société pour l’exercice clos le 25 janvier 2020 exigés par l’article 4.2...

MENLO PARK, Calif., May 22, 2020 (GLOBE NEWSWIRE) — Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced the pricing of its previously announced underwritten public offering of 107,049,375 shares of its common stock and pre-funded warrants to purchase 8,335,239 shares of common stock, together with accompanying warrants to purchase 57,692,307 shares of common stock. The common stock and pre-funded warrants will be sold in combination with an accompanying warrant to purchase 0.5 of a share of common stock issued for each share of common stock or pre-funded warrant sold. The combined offering price to the public of each share of common stock and accompanying warrant is $1.30. The combined offering price to the public of each pre-funded warrant and accompanying warrant is $1.299.All of...

ATLANTA, May 22, 2020 (GLOBE NEWSWIRE) — Chart Industries, Inc. (NASDAQ: GTLS) a leading diversified global manufacturer of highly engineered equipment for the industrial gas and energy industries, today released our ESG Performance Report, which is contained as a supplement to this release. As part of the report, we highlight our carbon reduction efforts as well as how we support our customers to achieve their net carbon zero emissions targets.Chart is proud to be at the forefront of the clean energy transition as a leading provider of the technology, equipment and services related to liquefied natural gas, hydrogen, biogas and biomethane amongst other applications. This leadership position is possible not only because we have the broadest offering of innovative solutions for industrial gas and energy, but also because we are committed...

OMER, Israel, May 22, 2020 (GLOBE NEWSWIRE) — ScoutCam (OTC: SCTC), a company developing and manufacturing customized visual solutions to organizations by offering the world’s smallest cameras and supplementary technologies, today announced a breakthrough with the successful integration of the company’s wireless micro ScoutCam into medical endoscope devices, formally introducing the healthcare industry’s first operating room-ready wireless endoscope, to the company’s knowledge.The device, which has been cleared for marketing by the U.S. Food and Drug Administration (FDA) and meets the Federal Communications Commission requirements, was developed for a privately held orthopedic company.We believe that the wireless endoscope product revolutionizes the endoscopy industry by implementing a single-use micro camera for medical...

Ola Holen, Chairman of the Board of Hofseth BioCare ASA, has in connection to the upcoming Annual General Meeting on 25 May 2020, received proxy rights from shareholders representing 158 596 305 shares in the company, equal to approx. 48.2 per cent of the voting rights.Mr. Holen owns as per the registration date for the AGM a total of 1 465 253 shares, equal to 0.45 per cent of the outstanding shares in HBC. 935 388 shares is owned via his fully owned company, Paso AS, and 529 865 shares are held privately.After the receipt of the above-mentioned proxies, Mr. Holen represents a total of 160 061 558 shares, equal to 48.64 per cent of the voting rights at the Annual General meeting in Hofseth BioCare ASA.For further information, please contact:Jon Olav Ødegård, CFO of Hofseth BioCare ASAMob: +47 93632966E-mail: joo@hofsethbiocare.noAbout...

Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12